
AHR Stock Forecast & Price Target
AHR Analyst Ratings
Bulls say
American Healthcare REIT Inc. (AHR) is poised for significant growth due to its favorable acquisition strategy, with an anticipated additional $600 million in acquisitions by 2026, which will enhance its already diversified healthcare real estate portfolio. The company's key operator, Trilogy, is expected to benefit from improved Medicare Advantage reimbursement rates by enhancing occupancy and enhancing the quality mix, which are both vital for sustaining growth in both senior housing and skilled nursing facilities. Furthermore, AHR's strategic move to lower its cost of capital allows for more aggressive and accretive capital deployment, positioning the company well for stronger organic growth and overall investment performance.
Bears say
American Healthcare REIT faces potential negative pressures due to economic headwinds and regulatory changes that could adversely affect tenant performance, impacting the company’s ability to meet earnings expectations. The company is also exposed to acquisition risks, with anticipated lower initial yields and the possibility of missing organic NOI growth expectations that could further harm stock performance. Additionally, the reliance on skilled nursing facilities for a significant portion of income introduces heightened volatility, leaving the REIT vulnerable to operational challenges and broader market fluctuations.
This aggregate rating is based on analysts' research of American Healthcare REIT Inc and is not a guaranteed prediction by Public.com or investment advice.
AHR Analyst Forecast & Price Prediction
Start investing in AHR
Order type
Buy in
Order amount
Est. shares
0 shares